(Q84857902)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878378%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878378%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

Huixia Lv

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21878378

11 December 2024

Jianjun Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878378%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Kun Jiang

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878378%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Yuan Gao

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878378%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21878378

11 December 2024

publication date

22 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878378%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

11 February 2020

https://api.elsevier.com/content/article/PII:S037851731100785X?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

https://api.elsevier.com/content/article/PII:S037851731100785X?httpAccept=text/plain

11 December 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

International Journal of Pharmaceutics

11 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878378%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

420

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878378%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878378%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

180-188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878378%20AND%20SRC:MED&resulttype=core&format=json

Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Pharmacological evaluation of several major ingredients of Chinese herbal medicines in human hepatoma Hep3B cells.

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Physicochemical and pharmacokinetic characterization of a spray-dried cefpodoxime proxetil nanosuspension.

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Evaluation of the anti-inflammatory effect of baicalein on dextran sulfate sodium-induced colitis in mice

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Production and characterization of a budesonide nanosuspension for pulmonary administration

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Absorption and safety of alendronate, a nitrogen-containing bisphosphonate, after intrapulmonary administration in rats.

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Nanosizing--oral formulation development and biopharmaceutical evaluation

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers.

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Studies on Scutellariae Radix

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Beta-Catenin mediates the anti-adipogenic effect of baicalin

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

A rapid HPLC method for the quantification of 3,5,4'-trimethoxy-trans-stilbene (TMS) in rat plasma and its application in pharmacokinetic study

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Development of an oral rutin nanocrystal formulation

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Kinetic solubility and dissolution velocity of rutin nanocrystals

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

State of the art of nanocrystals--special features, production, nanotoxicology aspects and intracellular delivery.

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Characterization of human insulin microcrystals and their absorption enhancement by protease inhibitors in rat lungs.

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Nanosuspensions in drug delivery

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Mechanism of CYP2C9 inhibition by flavones and flavonols

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Zinc coupling potentiates anti-HIV-1 activity of baicalin

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Absorption and enterohepatic circulation of baicalin in rats

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Preparation and antitumor study of camptothecin nanocrystals

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Micronization of atorvastatin calcium by antisolvent precipitation process.

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Role of intestinal first-pass metabolism of baicalein in its absorption process.

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Mechanistic study on the intestinal absorption and disposition of baicalein.

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

Involvement of UDP-glucuronosyltransferases in the extensive liver and intestinal first-pass metabolism of flavonoid baicalein.

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJPHARM.2011.08.023

11 December 2024

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878378%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21878378%20AND%20SRC:MED&resulttype=core&format=json